Apex Healthcare Berhad (KLSE:AHEALTH)

Market Cap	1.73B
Revenue (ttm)	954.49M
Net Income (ttm)	68.09M
Shares Out	720.39M
EPS (ttm)	0.10
PE Ratio	25.21
Forward PE	20.40
Dividend	0.09 (3.75%)
Ex-Dividend Date	Sep 4, 2025

Volume	61,300
Average Volume	83,135
Open	2.440
Previous Close	2.440
Day's Range	2.360 - 2.440
52-Week Range	1.900 - 2.770
Beta	0.20
RSI	40.22
Earnings Date	Aug 20, 2025

About Apex Healthcare Berhad

Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, anti-diabetic, anti-hypertensive, neuromuscular agent, analgesic, dermatological, and ophthalmological products in the form of tablets, capsules, oral liq...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 976
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: AHEALTH

Financial Performance

In 2024, Apex Healthcare Berhad's revenue was 961.78 million, an increase of 2.74% compared to the previous year's 936.17 million. Earnings were 76.54 million, a decrease of -80.77%.